-
Information-Publications
-
Discovery of a novel ALK/ROS1/FAK inhibitor, APG-2449, in preclinical non-small cell lung cancer and ovarian cancer modelsDetails
-
Celastrol alleviates subconjunctival fibrosis induced by silicone implants mimicking glaucoma surgeryDetails
-
Dysregulation of iron homeostasis by TfR-1 renders EZH2 wild type diffuse large B-cell lymphoma resistance to EZH2 inhibitionDetails
-
Luhong Formula and Hydroxysafflor yellow A protect cardiomyocytes by inhibiting autophagyDetails
-
Synthesis and biological evaluation of celastrol derivatives as potent antitumor agents with STAT3 inhibitionDetails
-
Engineer a double team of short-lived and glucose-sensing bacteria for cancer eradicationDetails
-
"Heyuan Liji" is a joint venture between Heyuan Biotechnology (stock code: 688238) and Liji Biotechnology, specializing in the "Liji Biotechnology" and "Life-ilab" reagent brands